• Skip to primary navigation
  • Skip to main content
  • Skip to footer
ElevateBio

ElevateBio

Cell and Gene Therapy Innovation Right From The Start

  • Investors & Media
    • Investors & Media Overview
    • Press Releases
    • Events & Presentations
    • Elevated Insights
  • Careers
  • Contact
  • Search
  • End-to-End Capabilities
    • End-to-End Capabilities Overview
    • cGMP Manufacturing and Automation
    • Process Development
    • Analytical Services and Quality
    • Enabling Services
  • Technology Platforms
    • Technology Platforms Overview
    • Gene Editing
    • Induced Pluripotent Stem Cells (iPSCS)
    • RNA, Cell, Protein & Vector Engineering
  • Therapeutic Design & Approaches
    • Therapeutic Design & Approaches Overview
    • Ex Vivo Cell & Gene Therapies
    • In Vivo Gene Therapies
  • Partnering
    • Partnering Overview
    • Industry Partnerships
    • Academic Partnerships
  • About
    • About Overview
    • Our Story
    • Our Ecosystem
    • Our Team
    • Culture of Expedition
    • Careers
  • Investors & Media
    • Investors & Media Overview
    • Press Releases
    • Publications
    • Elevated Insights
  • Careers
  • Contact
  • End-to-End Capabilities


    End-to-End Capabilities Overview

    • cGMP Manufacturing and Automation
    • Process Development
    • Analytical Services and Quality
    • Enabling Services
  • Technology Platforms


    Technology Platform Overview

    • Gene Editing
    • Induced Pluripotent Stem Cells (iPSCS)
    • RNA, Cell, Protein & Vector Engineering
  • Therapeutic Design & Approaches


    Therapeutic Design & Approaches Overview

    • Ex Vivo Cell & Gene Therapies
    • In Vivo Gene Therapies
  • Partnering
    • Partnering Overview
    • Industry Partnerships
    • Academic Partnerships
  • About
    • About Overview
    • Our Story
    • Our Ecosystem
    • Our Team
    • Culture of Expedition
    • Careers

Explore
More

  • Gene Editing
  • Induced Pluripotent Stem Cells (iPSCS)
  • RNA, Cell, Protein & Vector Engineering
Home/Technology Platforms/RNA, Cell, Protein & Vector Engineering

RNA, Cell, Protein, & Vector Engineering

Enabling the manufacturing, development and design of cell and gene therapies through engineering

// Technology
   Platforms

Engineering at the Center of Cell and Gene Therapy Innovation

We have built multiple engineering technology platforms that are essential to the construct, design, and scaling of cell and gene therapies. Through our engineering technologies, we have centralized these technologies to ensure internal programs and external partners have access to the necessary tools to build novel therapies.

An Integrated Ecosystem of Engineering Technology

Each engineering platform is fully integrated within the ElevateBio® ecosystem to improve productivity and scalability of the therapies we develop and manufacture.

RNA, Cell, Protein, & Vector Engineering

RNA Engineering
Cellular Engineering
Protein Engineering
Vector Engineering
RNA Engineering

RNA Engineering

We are developing novel technologies to deliver RNA molecules to cells to provide genetic instructions to make specific proteins, which can treat or prevent disease, or to disrupt the production of disease-causing proteins.

Cellular Engineering

Cellular Engineering

We have developed multiple platforms aimed at overcoming the immunosuppressive tumor microenvironment and enhancing immune cell function and proliferation in cell therapies.
Protein Engineering

Protein Engineering

Our protein engineering platform can help improve the efficiency and specificity of new technologies, including the continued advancement of antigen receptors, binders, and endonucleases.

Vector Engineering

Vector Engineering

Our viral vector engineering technologies can support all stages of development, including gene delivery and end-to-end process development and manufacturing for lentiviral and adeno-associated virus (AAV) vectors, across different cell types and payloads.

Our Integrated Technology Platforms Fueling the Discoveries of Tomorrow

Gene
Editing

We have a powerful suite of proprietary gene editing technologies to accelerate the development of life-changing and curative therapies for patients.

Learn about gene editing

Induced Pluripotent Stem Cells (iPSCs)

We are setting a new standard with well-characterized induced pluripotent stem cell (iPSC) lines that are suitable for research, clinical and commercial use.

Learn about IPSCS

Our Therapeutic Approaches

We are enabling the development of a range of ex vivo and in vivo cell and gene therapies, leveraging our in-house capabilities and expertise to design and develop an array of modalities.

Learn about our therapeutic designs

End-to-End Capabilities

We help our partners scale new heights in cell and gene therapies by providing a full spectrum of viral vector and cell therapy capabilities to bring concepts to commercialization.

Learn about our Basecamp® capabilities

Partner with ElevateBio®

Wherever you are in your cell and gene therapy product lifecycle, we can strengthen and accelerate the development of your transformative therapies with our enabling technologies unmatched manufacturing capabilities.

Work with Us

// Work with us

Footer

ElevateBio

Investors & Media

LinkedIn Twitter

© 2023 ElevateBio. All Rights Reserved.

Privacy & Cookie Policy

  • End-to-End Capabilities
  • Technology Platforms
  • Therapeutic Design & Approaches
  • Partnering
  • About
  • Investors & Media
  • Careers
  • Contact